MXPA03000053A - Aril y heteroaril diazabicicloalcanos, su preparacion y uso. - Google Patents

Aril y heteroaril diazabicicloalcanos, su preparacion y uso.

Info

Publication number: MXPA03000053A
Authority: MX; Mexico
Prior art keywords: diseases; disorders; aryl; nervous system; disorders related
Prior art date: 2000-07-04

Application number

MXPA03000053A

Other languages

English (en)

Inventor

Dan Peters

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-04

Filing date

2001-06-20

Publication date

2003-09-25

2001-06-20 Application filed by Neurosearch As filed Critical Neurosearch As

2003-09-25 Publication of MXPA03000053A publication Critical patent/MXPA03000053A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)

MXPA03000053A 2000-07-04 2001-06-20 Aril y heteroaril diazabicicloalcanos, su preparacion y uso. MXPA03000053A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200001037		2000-07-04
PCT/DK2001/000432 WO2002002564A1 (en)	2000-07-04	2001-06-20	Aryl and heteroaryl diazabicycloalkanes, their preparation and use

Publications (1)

Publication Number	Publication Date
MXPA03000053A true MXPA03000053A (es)	2003-09-25

Family

ID=8159596

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03000053A MXPA03000053A (es)	2000-07-04	2001-06-20	Aril y heteroaril diazabicicloalcanos, su preparacion y uso.

Country Status (12)

Country	Link
US (1)	US7060699B2 (es)
EP (1)	EP1301514B1 (es)
JP (1)	JP2004502692A (es)
CN (1)	CN1185233C (es)
AT (1)	ATE287888T1 (es)
AU (2)	AU2001265831B9 (es)
CA (1)	CA2410945A1 (es)
DE (1)	DE60108639T2 (es)
HK (1)	HK1057550A1 (es)
MX (1)	MXPA03000053A (es)
NZ (1)	NZ522793A (es)
WO (1)	WO2002002564A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004538268A (ja) *	2001-06-01	2004-12-24	ニューロサーチ、アクティーゼルスカブ	Ｃｎｓ−モジュレーターとしての新規ヘテロアリール−ジアザビシクロアルカン類
ATE378048T1 (de) *	2002-12-06	2007-11-15	The Feinstein Inst Medical Res	Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
US7238715B2 (en) *	2002-12-06	2007-07-03	The Feinstein Institute For Medical Research	Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
JP2007504229A (ja) *	2003-09-02	2007-03-01	メルク　エンド　カムパニー　インコーポレーテッド	代謝調節型グルタミン酸受容体−５のモジュレーターとしてのビピリジルアミン類およびエーテル類
US20050065178A1 (en) *	2003-09-19	2005-03-24	Anwer Basha	Substituted diazabicycloakane derivatives
US7399765B2 (en)	2003-09-19	2008-07-15	Abbott Laboratories	Substituted diazabicycloalkane derivatives
US7365193B2 (en)	2004-02-04	2008-04-29	Abbott Laboratories	Amino-substituted tricyclic derivatives and methods of use
US20050171079A1 (en) *	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
US7622486B2 (en) *	2004-09-23	2009-11-24	Reddy Us Therapeutics, Inc.	Pyridine compounds, process for their preparation and compositions containing them
DE602006019561D1 (de)	2005-02-16	2011-02-24	Neurosearch As	Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin-acetylcholin-rezeptoren
EP1863819B1 (en) *	2005-02-16	2011-01-12	NeuroSearch A/S	Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors
JP5214096B2 (ja) *	2005-06-17	2013-06-19	富士フイルムファインケミカルズ株式会社	新規なビピリジン誘導体
US7897766B2 (en)	2005-09-23	2011-03-01	Abbott Laboratories	Amino-aza-adamantane derivatives and methods of use
US8316104B2 (en)	2005-11-15	2012-11-20	California Institute Of Technology	Method and apparatus for collaborative system
DE602006015523D1 (de) *	2005-12-06	2010-08-26	Neurosearch As	Neue diazabicyclische arylderivate und medizinische verwendung dafür
JP2009526024A (ja)	2006-02-10	2009-07-16	ノイロサーチアクティーゼルスカブ	ニコチン性アセチルコリン受容体アゴニストとしての３−ヘテロアリール−３，９−ジアザビシクロ［３．３．１］ノナン誘導体
EP1984366B1 (en)	2006-02-10	2010-12-15	NeuroSearch A/S	3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
CA2641678A1 (en)	2006-02-10	2007-08-16	Neurosearch A/S	3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US7910578B2 (en)	2006-05-23	2011-03-22	Neurosearch A/S	8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
US8314119B2 (en)	2006-11-06	2012-11-20	Abbvie Inc.	Azaadamantane derivatives and methods of use
SI2195312T1 (sl) *	2007-10-09	2013-01-31	Merck Patent Gmbh	Derivati piridina, uporabni kot aktivatorji glukokinaze
US20110142758A1 (en) *	2008-06-10	2011-06-16	Neurosearch A/S	Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
RU2016105706A (ru)	2010-09-23	2018-11-22	Эббви Бахамаз Лтд.	Моногидрат производного азаадамантана
EP3362819A4 (en)	2015-10-14	2019-06-05	Shenzhen Xpectvision Technology Co., Ltd.	X-RAY DETECTORS TO LIMIT DIFFUSION OF CHARGE CARRIER
KR102668690B1 (ko) *	2016-08-02	2024-05-28	삼성디스플레이 주식회사	헤테로고리 화합물 및 이를 포함한 유기 발광 소자

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT403803B (de) *	1996-04-19	1998-05-25	Sanochemia Ltd	Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
ATE267199T1 (de) *	1997-05-30	2004-06-15	Neurosearch As	8-azabicyclo(3,2,1)oct-2-en- und octanderivate als liganden der nicotinergen ach rezeptoren
DK0984966T3 (da) *	1997-05-30	2003-05-05	Neurosearch As	9-azabicyclo[3.3.1]non-2-en derivater, som er cholinerge ligander på nikotin-ACh receptorer
US7265115B2 (en) *	1999-01-29	2007-09-04	Abbott Laboratories	Diazabicyclic CNS active agents
ES2209825T3 (es) *	1999-01-29	2004-07-01	Abbott Laboratories	Derivados diazabiciclicos utiles como ligandos del receptor nicotinico de la acetilcolina.
NZ513575A (en) *	1999-05-04	2003-07-25	Neurosearch As	Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators

2001
- 2001-06-20 MX MXPA03000053A patent/MXPA03000053A/es active IP Right Grant
- 2001-06-20 CN CNB018121004A patent/CN1185233C/zh not_active Expired - Fee Related
- 2001-06-20 JP JP2002507816A patent/JP2004502692A/ja not_active Withdrawn
- 2001-06-20 AU AU2001265831A patent/AU2001265831B9/en not_active Ceased
- 2001-06-20 AU AU6583101A patent/AU6583101A/xx active Pending
- 2001-06-20 AT AT01943186T patent/ATE287888T1/de not_active IP Right Cessation
- 2001-06-20 US US10/276,160 patent/US7060699B2/en not_active Expired - Fee Related
- 2001-06-20 CA CA002410945A patent/CA2410945A1/en not_active Abandoned
- 2001-06-20 DE DE60108639T patent/DE60108639T2/de not_active Expired - Lifetime
- 2001-06-20 EP EP01943186A patent/EP1301514B1/en not_active Expired - Lifetime
- 2001-06-20 NZ NZ522793A patent/NZ522793A/en unknown
- 2001-06-20 WO PCT/DK2001/000432 patent/WO2002002564A1/en active IP Right Grant
2004
- 2004-01-15 HK HK04100323A patent/HK1057550A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ522793A (en)	2005-02-25
DE60108639T2 (de)	2005-07-07
HK1057550A1 (en)	2004-04-08
CA2410945A1 (en)	2002-01-10
US7060699B2 (en)	2006-06-13
CN1185233C (zh)	2005-01-19
AU2001265831B2 (en)	2006-07-27
ATE287888T1 (de)	2005-02-15
CN1440411A (zh)	2003-09-03
DE60108639D1 (de)	2005-03-03
AU2001265831B9 (en)	2006-08-31
WO2002002564A1 (en)	2002-01-10
EP1301514A1 (en)	2003-04-16
EP1301514B1 (en)	2005-01-26
JP2004502692A (ja)	2004-01-29
AU6583101A (en)	2002-01-14
US20030176416A1 (en)	2003-09-18

Publication	Publication Date	Title
AU6583101A (en)	2002-01-14	Aryl and heteroaryl diazabicycloalkanes, their preparation and use
PL375025A1 (en)	2005-11-14	Novel 1,4-diazabicycloalkane derivatives, their preparation and use
AU2002220517A1 (en)	2002-06-11	3-substituted quinuclidines and their use as nicotinic agonists
MXPA04010966A (es)	2005-01-25	Derivados novedosos de biarilo diazabiciclico.
AU2003280309A1 (en)	2004-06-03	1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof
HK1080860A1 (en)	2006-05-04	Novel quinuclidine derivatives and their use
WO2006087306A3 (en)	2006-11-23	Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors
IL176260A0 (en)	2006-10-05	Diazabicyclic aryl derivatives as cholinergic receptor modulators
ATE289310T1 (de)	2005-03-15	Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren
MXPA04000012A (es)	2004-05-21	Compuestos novedosos, su preparacion y uso.
MX2007004269A (es)	2007-06-15	Derivados de arilo diazabiciclico nuevos y su uso medico.
MXPA05006861A (es)	2005-12-12	Derivados arildiazabiciclicos novedosos.
DE60307102D1 (de)	2006-09-07	3-substituierte chinuklidine und deren verwendung
WO2005111033A3 (en)	2006-01-12	Novel azabicyclic aryl derivatives
MXPA05003344A (es)	2005-11-23	Derivados novedosos de 1,4-diazabicicloalcano, su preparacion y uso.
MXPA04010965A (es)	2005-01-25	Derivados de etinilo azaciclico novedoso.
MX2007003331A (es)	2007-06-05	Nuevos derivados de arilo diazabiciclico.
HK1068878A1 (en)	2005-05-06	Novel 2, 5-diazabicyclo Ä2.2.1Üheptane derivatives
MX2007004245A (es)	2007-06-12	Nuevos derivados de arilo azabiciclicos y su uso medico.

Legal Events

Date	Code	Title	Description
2005-12-19	FG	Grant or registration